Search

everythinglearnresearchcommunity

for

Search:↓

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Kerascalp hair serum was found to be safe and effective in improving hair growth and strength in people with mild to moderate hair loss.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Combining minoxidil with MS injections leads to better hair regrowth in men.

Using platelet-rich plasma injections and biotin pills together significantly increases hair regrowth in men with hair loss.

Platelet Rich Plasma (PRP) treatment is safe and effective for hair growth in people with androgenic alopecia, and can also help treat bacterial infections.

Finasteride increases hair count and improves hair growth with low risk of side effects.

Low-dose oral minoxidil is effective and well-tolerated for treating hair loss.

IGF-1R may play a role in female hair loss and could be a treatment target.

Hair loss in women not always linked to increased oil production; other factors may be involved.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

A new hair loss classification for women improves treatment, but careful patient selection is crucial for successful hair transplantation.

Certain Prakruti types are more prone to early male pattern baldness.

Hair follicle culture helps develop new treatments for hair loss.

Dermoscopy shows that varying hair shaft thickness and single hair follicles are main signs of male pattern baldness, especially in the fronto-temporal region.

Men with early hair loss have lower vitamin D levels.

Testosterone and dihydrotestosterone affect hair growth, and new techniques like the folliculogram help study it, but fully understanding hair growth is still complex.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Platelet-rich plasma treatment is effective for increasing hair thickness and works well for hair density in men with androgenetic alopecia.

Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Hair transplantation is a viable treatment for some types of female hair loss, with careful donor assessment and attention to psychological factors.

Both methods improve hair density and thickness; double-spin may be more effective.

Special and immunohistochemical stains are not routinely needed for diagnosing hair disorders.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Finasteride increases hair growth, prolongs hair cycle, and lowers dihydrotestosterone levels.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Minoxidil effectively promotes hair regrowth in younger patients with small balding areas.

The nutritional supplement improved hair density and reduced hair loss in women with female pattern hair loss.